MSD - Research Centers

Research Centers

Building a global laboratory committed to excellence and scientific integrity

MSD's research efforts are global; its 12 centers around the globe are committed to excellence and scientific integrity. Together, they employ thousands of the world's best and brightest scientists. MSD recruits researchers who are leaders in their scientific and technical disciplines—people with the enthusiasm and drive to help provide medicines that save lives and improve the quality of life for our patients.

Merck Frosst Centre for Therapeutic Research

Montreal, Quebec, Canada
Aimed at discovering novel and improved therapeutic agents for the treatment of respiratory, inflammatory and other diseases, this leading-edge research facility is home to over 300 scientists. The Merck Frosst Centre for Therapeutic Research runs a wide variety of exciting new research programs, including gene expression technology and proteomics, as well as research into a novel phosphatase, protein tyrosine phosphatase 1B (PTP-1B), which holds potential for developing a new drug for endocrine disorders such as diabetes.

Learn more about the Merck Frosst Centre for Therapeutic Research

Other Worldwide Research Centers

Americas

Merck Research Labs, USA
Rahway, New Jersey
West Point, Pennsylvania
San Diego, California
Boston, Massachusetts (under development)


		Rosetta Inpharmatics, Inc. Kirkland, Washington, USA A wholly owned subsidiary of Merck & Co., Inc., designs and implements cutting-edge genomic research technologies to enable more accurate selection of drug targets and more efficient drug development.

Asia

Banyu Pharmaceutical Co., Ltd.
Tsukuba City, Japan
Engaged in research and development, manufacturing, marketing and sales of primarily cardiovascular and anti-inflammatory drugs and antibiotics.

Europe

Centro de Investigaciones Basica de España
Madrid, Spain
CIBE searches for organisms with the potential to evolve into commercial medicines. One recent discovery, antifungal extract caspofungina, is the first in a new class of drugs designed to counter fungal infections caused by Aspergillus, a fungus with a fatality rate of 50–90 percent.


		Institute for Research in Molecular Biology Pomezia, Italy One main research target of the institute is human hepatitis C infection, which affects hundreds of million people worldwide and for which there is no effective therapy. IRBM scientists have made great advances in the development of anti-HCV drugs.


		Laboratoires MSD, Chibret Research Center Rohm, France


		MSD Development Laboratories Hoddesdon, Herts, United Kingdom Pharmaceutical Research & Development team plays a vital role in the commercial development of the company's new products.


		The Neuroscience Research Centre at Terlings Park Harlow, Essex, United Kingdom Researches disorders and diseases of the brain. Develops treatments for patients suffering from neurological and psychiatric diseases.

Print version

Email a friend

Careers

Help us bring out the best in medicine.

Explore MSD Careers

"To know that you have contributed to making somebody's life better… that's a wonderful feeling."


		Dr. Sam McClintock Director of Pharmaceutical Research & Development, Merck Frosst Canada & Co.

This site is intended for residents of Republic of Indonesia.